Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer DiseaseEdmond Teng, Carlo de Lena, Michael Dolton et al.|JAMA Neurology|2022Cited by 188
Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s diseaseEdmond Teng, Robby M. Weimer, Paul T. Manser et al.|Alzheimer s Research & Therapy|2021Cited by 33
Cognitive indices correlate with [<sup>18</sup>F]GTP1 tau PET signal and white matter hyperintensities in prodromal‐to‐mild Alzheimer's disease: Baseline data from the Tauriel StudyEdmond Teng, Sandra Sanabria Bohórquez, Paul T. Manser et al.|Alzheimer s & Dementia|2020Cited by 2
Baseline correlations between [<sup>18</sup>F]GTP1 PET SUVR and MRI white matter hyperintensities in prodromal‐to‐mild Alzheimer's disease suggest independent contributions to cognitive impairmentPaul T. Manser, Sandra Sanabria Bohórquez, Karen Pickthorn et al.|Alzheimer s & Dementia|2020Cited by 1